BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 10329563)

  • 1. Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
    Steinhauer DA
    Virology; 1999 May; 258(1):1-20. PubMed ID: 10329563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of cleavage activation of the hemagglutinin by host and bacterial proteases in the induction of the pathogenesis of influenza viruses].
    Tashiro M
    Nihon Rinsho; 1997 Oct; 55(10):2633-9. PubMed ID: 9360383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potentiation of infectivity and pathogenesis of influenza virus by host and bacterial proteases].
    Nagatake T
    Nihon Rinsho; 2003 Nov; 61(11):1892-6. PubMed ID: 14619427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
    Guo YJ; Krauss S; Senne DA; Mo IP; Lo KS; Xiong XP; Norwood M; Shortridge KF; Webster RG; Guan Y
    Virology; 2000 Feb; 267(2):279-88. PubMed ID: 10662623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
    Kido H; Murakami M; Oba K; Chen Y; Towatari T
    Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemagglutinin: a determinant of pathogenicity.
    Böttcher-Friebertshäuser E; Garten W; Matrosovich M; Klenk HD
    Curr Top Microbiol Immunol; 2014; 385():3-34. PubMed ID: 25031010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza viruses, cell enzymes, and pathogenicity.
    Rott R; Klenk HD; Nagai Y; Tashiro M
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S16-9. PubMed ID: 7551406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation.
    Chen J; Lee KH; Steinhauer DA; Stevens DJ; Skehel JJ; Wiley DC
    Cell; 1998 Oct; 95(3):409-17. PubMed ID: 9814710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
    Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
    Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between structure and pathogenicity of myxoviruses (author's transl)].
    Rott R; Klenk HD; Scholtissek C
    Arzneimittelforschung; 1977 Jan; 27(1B):208-12. PubMed ID: 576826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.
    Stevens J; Corper AL; Basler CF; Taubenberger JK; Palese P; Wilson IA
    Science; 2004 Mar; 303(5665):1866-70. PubMed ID: 14764887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics.
    Garten W; Braden C; Arendt A; Peitsch C; Baron J; Lu Y; Pawletko K; Hardes K; Steinmetzer T; Böttcher-Friebertshäuser E
    Eur J Cell Biol; 2015; 94(7-9):375-83. PubMed ID: 26095298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Adv Virus Res; 2009; 73():55-97. PubMed ID: 19695381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and receptor binding properties of the 1918 influenza hemagglutinin.
    Gamblin SJ; Haire LF; Russell RJ; Stevens DJ; Xiao B; Ha Y; Vasisht N; Steinhauer DA; Daniels RS; Elliot A; Wiley DC; Skehel JJ
    Science; 2004 Mar; 303(5665):1838-42. PubMed ID: 14764886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of and immunity to avian influenza A H5 viruses.
    Katz JM; Lu X; Frace AM; Morken T; Zaki SR; Tumpey TM
    Biomed Pharmacother; 2000 May; 54(4):178-87. PubMed ID: 10872716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
    Lee CW; Lee YJ; Senne DA; Suarez DL
    Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
    Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
    Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cleavage of the hemagglutinin protein of H5N2 avian influenza virus in yeast.
    Wang CY; Luo YL; Chen YT; Li SK; Lin CH; Hsieh YC; Liu HJ
    J Virol Methods; 2007 Dec; 146(1-2):293-7. PubMed ID: 17727967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.